Approval · Notice of Compliance 4812 · 1995
TRASYLOL: Notice of Compliance 4812
Issued November 29, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4812
- Date
- November 29, 1995
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revision to the product monograph
- Therapeutic class
- Hemostatic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRASYLOL | 02186845 | Dormant |
Medicinal ingredients
- APROTININ 10,000 UNIT per ML